DIABETIC KETOACIDOSIS

This adverse event was reported 24045 times

These drugs are most commonly taken by patients reporting DIABETIC KETOACIDOSIS:

# Drug Count
0 EMPAGLIFLOZIN 3903
1 METFORMIN 3617
2 METFORMIN ER 500 MG 3617
3 METFORMIN ER 750 MG 3617
4 CANAGLIFLOZIN 3441
5 INSULIN GLARGINE 2644
6 INSULIN LISPRO 1796
7 DAPAGLIFLOZIN 1648
8 QUETIAPINE 1437
9 INSULIN ASPART 1361
See all common drugs associated with DIABETIC KETOACIDOSIS

DIABETIC KETOACIDOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANAGLIFLOZIN 3441 0.1152
1 CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 163 0.0898
2 EMPAGLIFLOZIN AND LINAGLIPTIN 149 0.0758
3 ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE 6 0.0732
4 EMPAGLIFLOZIN 3903 0.0562
5 EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE 190 0.0533
6 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 156 0.0529
7 INAVOLISIB 34 0.0507
8 DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 177 0.0505
9 ERTUGLIFLOZIN 54 0.0484
See all drugs enriched for association with DIABETIC KETOACIDOSIS